Intervention in the aging immune system: Influence of dietary restriction, dehydroepiandrosterone, melatonin, and exercise

Journal of the American Aging Association

Volumn 21, Issue 4, 1998, Pages 153-173

  Pahlavani, Mohammad A ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 3; MELATONIN; PRASTERONE;

AGING; ANIMAL CELL; ANIMAL TISSUE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; EXERCISE; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE SYSTEM; IMMUNOMODULATION; META ANALYSIS; NONHUMAN; RAT; REVIEW; SENESCENCE; STRAIN DIFFERENCE;

EID: 2542622772     PISSN: 01619152     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11357-998-0025-5     Document Type: Article

References (179)

1. Makinodan, T. and Kay, M.B.: Age influence on the immune system. Adv. Immunol., 29:287-296, 1980.
2. Pahlavani, M. A.: Immunological aspects of aging. Drugs of Today, 23:611-624, 1987.
3. Thoman, M. L and Weigle, W.O.: The Cellular and Subcellular Bases of Immunosenescence. Adv. Immunol., 46:221-237, 1987.
4. Murasko, D. M. and Goonewardene, I.M.: T-Cell Function in Aging: Mechanisms of Decline. Ann. Rev. Gerontol., 10:71-88, 1990.
5. Miller, R. A.: Aging and immune function. Int. Rev. Cytol., 124:187-193, 1991.
6. Hirokawa, K.: Autoimmunity and Aging. In J.M. Cruse and R.E.J. Lewis (eds.), Autoimmunity: Basic Concepts: Systemic and Selected Organ-Specific Diseases, Karger, Basel, pp. 251-288, 1985.
7. Hirokawa, K.: Aging and the immune system. In A.M. Kligman and Y. Takase (eds.), Cutaneous Aging, University of Tokyo Press, pp. 61-78, 1988.
8. Walford, R. L.: Immunologic theory of aging: Current status. FASEB J., 33:2020., 1974.
9. Fabris, N., Pierpaoli, W., and Sorkin, E.: Lymphocytes, Hormones, and Aging. Nature, 240:557-559, 1972.
10. Hirokawa, K., Sato, K., and Makinodan, T.: Restoration of impaired immune function in aging animals. V. Long-term immunopotentiating effects of combined young bone marrow and new born thymus grafts. Clin. Immunol. Immunopathol., 22: 297-304, 1982.
11. Astle, C.M. and Harrison, D.E.: Effects of marrow donor and recipient age on immune responses. J. Immunol., 132:673-677, 1984.
12. Hirokawa, K.: Reversing and restoring immune functions. Mech. Ageing Dev., 93:119-124, 1997.
13. Pahlavani, M.A. and Richardson, A.: The effect of age on the expression of interleukin-2. Mech. Ageing Dev., 89:125-154, 1996.
14. Effros, R.B., Casillas, A., and Walford, R.L.: The effect of thymosin on immunity to influenza in aged mice. Aging Immunol. Infect. Dis., 1:31-40, 1988.
15. Goso, C., Frasca, D., and Doria, D.: Effect of synthetic thymic humoral factor (THF-γ2) on T cell activities in immunodeficient aging mice. Clin. Exp. Immunol., 87:346-351, 1992.
16. Daynes RA, Araneo BA.: Prevention and reversal of some age-associated changes in immunologic responses by supplemental dehydroepiandrosterone sulfate therapy. Aging: Immunol. & Infect. Dis., 3:135-153., 1992.
17. Araneo BA, Woods ML, II, Daynes RA.: Reversal of the immunosenescent phenotype by dehydroepiandrosterone: Hormone treatment provides an adjuvant effect on the immunization of aged mice with recombinant hepatitis B surface antigen. J. Infect. Dis., 167: 830-840, 1993.
18. Maestroni, G.J, Conti, A., and Pierpaoli, W.: Pineal melatonin, its fundamental immunoregulatory role in aging and cancer. Ann. Ny. Acad. Sci., 521:140-148, 1988.
19. Caroleo, M.C., Frasca, D., Nisticok, G, and Doria, G.: Melatonin as immunomodulator in immunodeficient mice. Immunopharmacol., 23:81-89, 1992.
20. Weindruch, R. H., Kriste, J.A., Naeim, F., Mullen, B.G., and Walford, R.L.: Influence of weaning-initiated dietary restriction on responses of T cell mitogens and on splenic T cell levels in a long-lived F1-hybrid mouse strain. Exp. Gerontol., 17:49-64, 1982.
21. Fernandes, G.: Nutritional Factors: Modulating effects on immune function and aging. Pharmacol. Rev., 36:123S-129S, 1984.
22. Pahlavani, M.A., Cheung, H.T., Chesky, J.A. and Richardson, A.: Influence of exercise on the immune function of rats of various ages. J. Appl. Physiol., 64:1997-2001, 1988.
23. Nasrullah, I. And Mazzeo, R.S.: Age-related immunosenescence in Fischer 344 rats: Influence of exercise training. J. Appl. Physiol., 73:1932-1938, 1992.
24. Venkatraman, J.T., and Fernandes, G.: Exercise, immunity and aging. Aging Clin. Exp., 9:4256, 1997.
25. Chandra, R.K.: Effect of vitamin and trace-element supplementation on immune responses and infection in elderly subjects. Lancet, 340:1124-1127, 1992.
26. Bogden, J.D., Bendich, A., Kemp, F.W., Bruening, K.S., Shurnick, J.H., Denny, T., Baker, H., and Louria, D.B.: Daily micronutrient supplements enhance delayed hypersensitivity skin test responses in older people. Am. J. Clin. Nutr., 60:437-447, 1994.
27. Meydani, S.N., Meydani, M., Blumberg, J.B., Leka, L.S., Siber, G., Loszewski, R., Thompson, C., Pedrosa, M.C., Diamond, R.D., and Stollar, B.D.: Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial. JAMA 277:1380-1386, 1997.
28. Masoro, E. J., Shimokawa, I., Higami, Y., McMahan, C. A. and Yu, B.P.: Temporal pattern of food restriction not a factor in the restoration of aging process by dietary restriction. J. Gerontol., 50:B48-B53, 1995.
29. Richardson A.: The effect of age and nutrition on protein synthesis by cells and tissues from mammals, in CRC Handbook of Nutrition and Aging. Watson, R.R., Ed., CRC Press, Boca Ration, FL, 31, 1985.
30. Weindruch, R.H., Kriste, J.A., Cheney, K.E., and Walford, R.L.: Influence of controlled dietary restriction on immunologic function and aging. Fed. Proc., 38:2007-2016, 1979.
31. Regelson, W., Loria, R., and Kalami, M.: Dehydroepiandrosterone (DHEA) - the "Mother Steroid". I. Immunologic action. Ann. N. Y. Acad. Sci., 719, 553-563, 1994.
32. Regelson, W., Kalimi, M., and Loria, R.: DHEA: some thoughts as to its biologic and clinical action. In: Kalimi M, Regelson W. eds. The Biologic role of Dehydroepi-androsterone (DHEA). Walter de Guyter: New York. pp. 405-445, 1990.
33. Maestroni, G.J, Conti, A., and Pierpaoli, W.: Pineal melatonin, its fundamental immunoregulatory role in aging and cancer. Ann. Ny. Acad. Sci., 1988, 521:140-148, 1988.
34. Maestroni, G., and Conti, A.: Melatonin and the immune-hematopoietic system. Theapeuric and adverse pharmacological correlates. Neuro-immunomodulation. 3:325-332, 1996.
35. McCay, C. M., Crowell, M.F., and Maynard, L.A.: The effect of retarded growth upon the length of life span and upon the ultimate body size. J. Nutr., 10:63-72, 1935.
36. Masoro, E. J. and McCarter, R.M.: Dietary Restriction as a Probe of Mechanisms of Senescence. Ann. Rev. Gerontol., Chapter 11:183-194, 1990.
37. Masoro, E. J.: Potential role of modulation of fuel use in the antiaging action of dietary restriction. Ann. NY Acad. Sci., 663:403-411, 1992.
38. Gerbase-Delima, M., R. K. Liu, K. E. Cheney, R. Mickey, and Walford, R.L.: Immune function and survival in the long-lived mouse strain subjected to undermutrition. Gerontologia, 21:184-193, 1975.
39. Fernandes, G., E. Yunis, J., and Good, R.A.: Influence of protein restriction on immune function in NZB mice. J. Immunol., 116:782-788, 1976.
40. Venkatraman, J. and Fernandes, G.: Modulation of age-related alterations in membrane composition and receptor-associated immune functions by food restriction in Fischer 344 rats. Mech. Ageing Dev., 63:27-44, 1992.
41. Miller, R. A.: Caloric restriction and immune function: developmental mechanisms. Aging Clin. Exp. Res., 3:395-403, 1991.
42. Gilman-Sachs, A., Kim, Y.B., Pollard, M., and Snyder, L.D.: Influence of Aging, Environmental Antigens, and Dietary Restriction on Expression of Lymphocyte Subsets in Germ-free and Conventional Lobund-Wistar Rats. J. Gerontol., 46: B101-B109, 1991.
43. Pahlavani, M. A., Cheung, H.T., Cai, N.S., and Richardson, A.: Influence of dietary restriction and aging and gene expression in the immune system of rats. In Biomedical advances in aging. A.L. Goldstein, ed. Plenum Publishing Corp., New York, p. 259-270, 1990.
44. Lindquist, S.: The heat-shock response. Ann. Rev. Biochem., 55:1151-1191, 1986.
45. Lindquist, S., Craig, E.A.: The heat-shock proteins. Ann. Rev.Genet., 22:631-677, 1988.
46. Young, D.B.: Heat shock proteins: Immunity and Autoimmunity. (review). Current Opinion in Immunology, 4:396-400, 1992.
47. Sribvastava, P.K., Udono, H., Blachere, N.E., and Li, Z.: Heat shock proteins transfer peptides during antigen processing and CLT priming (review). Immunogenetics, 39:93-98, 1994.
48. Pahlavani, M.A., Harris, M.D., Moore, S.A., and Richardson, A.: Expression of heat shock protein 70 in rat spleen lymphocytes is affected by age but not by food restriction. N. Nutr., 126:2060-2075, 1996.
49. Byun, D.S., Venkartramann, J.T., Yu, B.P., and Fernandes, G.: Modulation of antioxidant activities and immune response by food restriction in aging Fischer 344 rats. Aging Clin. Exp., Res., 7:40-48, 1995.
50. Chayoth, R., Christou, N.V., Nohr, C.W., Yale, J.F., Poussier, P., Grose, M., Montambault, M., Chan, W., and Marliss, E.B.: Immunological responses to chronic heat exposure and food restriction in rats. Am. J. Clin. Nutr., 48:361-367, 1988.
51. Goonewardene, I.M. and Murasko, D.M.: Age-associated changes in mitogen-induced lympho-proliferation and lymphokine production in the long-lived Brown-Norway rat Effect of caloric restriction. Mech. Ageing Dev., 83:103-116, 1995.
52. Konno, A., Utsuyama, M., Kurashima, C., Kasai, M., Kimmura, S., and Hirokawa, K.: Effects of a protein-free diet or food restriction on the immune system of Wistar and Buffalo rats at different ages. Mech. Ageing and Dev., 72:183-197, 1993.
53. Pieri, C., Rechioni, R., and Moroni, F.: Food restriction in female Wistar rats. VI. Effect of reduced glutathione on the proliferative response of splenic lymphocytes from ad libitum fed and food restricted animals. Arch. Gerontol. Geriatr., 16:81-92, 1993.
54. Iwai, H. and Fernandes, G.: Immunological functions in food-restricted rats: enhanced expression of high-affinity interleukin-2 receptors on splenic T cells. Immunol. Lett., 23:125-132, 1990.
55. Fernandes, G., Venkatraman, J., Khare, A., Horbach, G.J., and Friedrichs, W.: Modulation of gene expression in autoimmune disease and aging by food restriction and dietary lipids. Proc. Soc. Exp. Biol. Med., 193:16-25, 1990.
56. Pahlavani, M.A. Harris, M.D., and Richardson, A.: The increase in the induction of IL-2 expression with caloric restriction is correlated to changes in the transcription factor NFAT. Cell, Immunol., 180:10-19, 1997.
57. Hishinuma, K., Nishimura, T., Konno, A., Hashimoto, Y., and Kimura, S.: The effect of dietary restriction on mouse T cell functions. Immunol. Lett., 17:351-359, 1988.
58. Weindruch, R. H., Kriste, J.A., Naeim, F., Mullen, B.G., and Walford, R.L.: Influence of weaning-initiated dietary restriction on responses of T cell mitogens and on splenic T cell levels in a long-lived F1-hybrid mouse strain. Exp. Gerontol., 17:49-64, 1982.
59. Weindruch, R.H., Kriste, J.A., Cheney, K.E., and Walford, R.L.: Influence of controlled dietary restriction on immunologic function and aging. Fed. Proc., 38:2007-2016, 1979.
60. Weindruch, R., Devens, B.H., Raff. H.V., and Walford, R.L.: Influence of dietary restriction and aging on natural killer cell activity in mice. J. Immunol., 130:993-996, 1983.
61. Grossmann, A., Price, L., Jinneman, J.C., Wolf, N.S., and Rabinovitch, P.S.: The effect of long-term caloric restriction on function of T cell subsets in old mice. Cell, Immunol., 131:191-204, 1990.
62. Cheney, K.E., Liu, R.K., Smith, G.S., Meredith, P.J., Michey, M.R., Walford, R.L.: The effect of dietary restriction of varying duration on survival, tumor patterns, immune function, and body temperature in B10C3F1 female mice. J. Gerontol., 38:420-430, 1983.
63. Venkatraman, J., Attwood, V.G., Turturro, A., Hart, R.W., and Fernandes, G.: Maintenance of virgin T cells and immune function by food restriction during aging in ling-lived B6D2F1 female mice. Aging: Immunol. Infec. Dis., 5:13-25, 1994.
64. Fernandes, G.: Nurtritional Factors: Modulating Effects on Immune Function and Aging. Pharmacol. Rev., 36:123S-129S., 1984.
65. Kubo, C., Johnson, B.C., Day, N.K., and Good, R.A.: Calorie Source, Calorie Restriction, Immunity and Aging of (NZB/NZW)F1 mice. J. Nutr., 114:1884-1899, 1984.
66. Fernandes, G., Friend, P., Yunis, E.J., and Good, R.A.: Influence of dietary restriction on immunological function and renal disease in (NZBXNZW)F1 mice. Proc. Natl. Acad. Sci. USA, 75:1500-1504, 1978.
67. Jung, L.K., Palladino, M.A., Calvano, S., Mark, D.A., Good, R.A., and Fernandes, G.: Effect of calorie restriction on the production and responsiveness to interleukin-2 in (NZB/NZX)F1 mice. Clin, Immunol., Immunopharmacol., 25:295-301, 1982.
68. Ellis, M.: An introduction to transcription. In Genes and Cancer. D. Carney and K. Sikora, eds. John Wiley and Sons, Chichester, UK, p. 107-118, 1990.
69. Angel, P., Allegretto, E.A., Okino, S.T., Hattari, K., Boyle, W.J., Hunter, T., and Karin,M.: Oncogene jun encodes a sequence-specific trans-activator similar to AP-1. Nature, 332:166-168, 1988.
70. Mitchell, P. J. and Tjian, R.: Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science, 245:371-373, 1989.
71. Ullman, K. S., Northrop, J-P., Verweij, C.L., and Crabtree, G.R.: Transmission of Signals from the T Lymphocyte Antigen Receptor to the Genes Responsible for Cell Proliferation and Immune Function: The Missing Link. Annu. Rev. Immunol., 8:421-443, 1990.
72. Riegel, J. S., Corthesy, B., Flanagan, W.M., and Crabtree, G.R.: Regulation of the Interleukin-2 Gene. Chem. Immunol.. 51:266-287, 1992.
73. Regelson, W., and Kalami, M.: Dehydroepiandrosterone (DHEA) - the Multifunctional Steroid. II. Effect on the CNS, cell proliferation, metabolic and vascular, clinical and other effects. Mechanism of Action. Ann. N. Y. Acad. Sci., 719, 564-575, 1994.
74. vy/A) mice by long term treatment with dehydroepiandrosterone. Cancer Res., 39: 1129-1132, 1979.
75. Parker C.R, and Schuster, M.W: Effects of syphilis infection on adrenocortical function in man. Proc. Soc. Exp. Biol. Med., 197:165-167, 1991.
76. Moolenar, A.J., Van Seters, A.P.: Gas-chromatographic determination of steroids in the urine of patients with Cushing's syndrome. Acta Endocrinology (Copenhagen), 67:303-315, 1971.
77. Keutman, E.H., Mason W.B.: Individual urinary 17-ketosteroids of healthy persons determined by gas-chromatograph-biochemical and clinical consideration. J. Clin. Endocrinol., 27:406-420, 1967.
78. Loria, R.M., Inge, T.H., Cook,S.: Protection against acute lethal viral infections with the native steroid dehydroepiandrosterone (DHEA). J. Med, Virol., 26: 301-314, 1988.
79. Loria, R.M., Regelson, W., Padget, D.A.: Immune response facilitation and resistance to viral and bacterial infections with DHEA. In: The Biologic Role of Dehydroepiandrosterone (DHEA). Kalimi, M., Regelson, W. (Eds.). Walter de Gruyter, New York, pp. 107-130, 1990.
80. Ben-Nathan D, Feuerstein G.: The influence of cold and isolation stress on resistance of mice to West Nile virus encephalitis. Experientia, 46:285-290, 1990.
81. Rasmussen, D.R., Martin, E.G., Arrowood, M.J.: Effect of dexamethasone and dehydroepiandrosterone in immunosuppressed rats infected with Crytosporidium parvum. J. Protozool., 38:157-159, 1991.
82. Araneo, B.A., Shelby, J., Li, G.Z.: Administration of dehydroepiandrosterone to burned mice preserves normal immunologic competence. Arch. Surg., 128:318-325, 1993.
83. Daynes, R.A., Dudley, D.J., Araneo, B.A.: Regulation of murine lymphokine production in vivo. II. Dehydroepiandrosterone is a natural enhancer of IL-2 synthesis by helper T-cells. Eur. J. Immunol., 20:793-801, 1990.
84. Padgett, D.A. and Loria, R.M.: In vitro potentiation of lymphocyte activation by dehydroepiandrosterone, androstenediol, and androstenetriol. J. Immunol., 153: 1544-1552, 1994.
85. Risdon, G., Cope, J., and Bennett, M.: Mechanisms of chemoprevention by dietary dehydroepiandrosterone: Inhibition of lymphopoiesis. Am. J. Pathol., 136:759-769, 1990.
86. Pahlavani, M.A. and Harris, M.D.: Effect of dehydroepiandrosterone on mitogen-induced lymphocyte proliferation and cytokine production in young and old F344 rats, Immunol. Lett., 47:9-14, 1995.
87. Blauer, K.L, Poth, M., Rogers, W.M., and Bernton, E.W.: Dehydroepiandrosterone antagonizes the suppressive effects of dexamethasone on lymphocyte proliferation. Endocrinol., 129:3174-3179, 1991.
88. Risdon, G.: Differential effects of DHEA on murine lymphopoiesis and myelopoiesis. Exp. Hematol., 19:128-131, 1991.
89. Matsunaga, A., Miller, B.C., Cottam, G.L.: Dehydroepiandrosterone prevention of autoimmune disease in NZB/WF1 mice: lack of an effect on associated immunological abnormalities. Biochem. Biophys. Acta., 992: 265-271, 1989.
90. Risdon, G., Cope, J., and Bennett, M.: Mechanisms of chemoprevention by dietary dehydroepiandrosterone: Inhibition of lymphopoiesis. Am. J. Pathol., 136:759-769, 1990.
91. Araneo, B.A., Dowell, T., Diegel, M., and Daynes, R.A.: Dehydroepiandrosterone exerts a depressive influence on the production of interieukin-4 (IL-4), IL-5, and interferon-gamma, but no IL-2 by activated murine T cells. Blood, 78:688-699, 1991.
92. Garg, M. and Bonada, S.: Reversal of age-associated decline in immune response to Pnu-Immune Vaccine by supplementation with the steroid hormone dehydroepiandrosterone. Infec. & Immunol., 61:2238-2241, 1993.
93. Weinduruch, R., McFeeters, G., and Walford, R.L.: Food intake reduction and immunologic alterations in mice fed dehydroepiandrosterone. Exp. Gerontol., 19:295-304, 1984.
94. Wiedmeier, S.E., Mu, H., Araneo, B.A., and Daynes, R.A.: Age and microenvironment-associated influences by platelet-derived growth factor on T cell function. J. Immunol., 152:3417-3425, 1994.
95. Daynes, R.A., Araneo, B.A., Ershler, W.B., Maloney, C., Li, G., and Ryu, S.: Altered regulation of IL-6 production with normal aging: Possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative. J. Immunol., 150:5219-5230, 1993.
96. May, M., Holmes, E., Rogers, W., and Poth, M.: Protection from glucocorticoid induced thymic involution by dehydroepiandrosterone. Life Science, 46:1627-1631, 1990.
97. Dyner, T.S., Lang, W., Geaga, L., Golub, A., Sites, D., Winger, E., Galmarini, M., Masterson, J., and Jacobson, M.A.: An open-label dose-escalation trial of oral dehydroepiandrosterone tolerance and pharmacokinetics in patients with HIV disease. J. Acquired Immune Deficiency Syndromes, 6:459-465, 1993.
98. Yang, J., Schwartz, A., and Henderson, E.: Inhibition of HIV-1 latency reactivation by dehydroepiandrosterone (DHEA) and an analog of DHEA. AIDS Res. And Human Retroviruses, 9:747-754, 1993.
99. Suzuki, T., Suzuki, N., Daynes, R.A.: Dehydroepiandrosterone enhances IL-2 production and cytotoxic effector function of human T-cells. Clin, Immunol. Immunopathol., 61:202-211, 1991.
100. Khorram, O., Vu, L., and Yen, S.: Activation of immune function by dehydroepiandrosterone (DHEA) in age-advanced men. J. Gerontol., 52A:M1-M7, 1997.
101. Maestroni, G.J, Conti, A.: Melatonin in relation to the immune system. In: Yu,H.S., Reiter, R.J. (eds), Melatonin:Biosynthesis, Physiological Effects and Clinical Applications. Boca Raton, CRC Press, pp. 290-306, 1993.
102. Maestroni, G.J.: The immunoendocrine role of melatonin. J. Pineal. Res., 14:1-10, 1993.
103. Pahlavani, M.A.: Role of melatonin in immunity, aging, and cancer: therapeutic intervention. Drugs of Today, 22:25-39, 1997.
104. Maestroni, G.M. and Pierpaoli, W.: Pharmacologic control of the hormonally mediated immune response. In: R. Ader (Ed.) Psychoneuro-immunology. Academic Press, New York, pp. 405-425, 1981.
105. Maestroni, G.M., Conti, A., and Pierpaoli, W.: Role of the pineal gland in immunity: Circadian synthesis and release of melatonin modulates the antibody response and antagonizes the immuno-suppressive effects of corticosterone. J. Neuroimmunol., 13:19-30, 1986.
106. Caroleo, M.C., Doria, G., and Nistico, G.: Melatonin restores immunodepression in aged and cyclophosphamide-treated mice. Ann. Ny. Acad. Sci., 719:343-352, 1994
107. Kuci, S., Becker, J., and Veit, G.: Circadian variations of the Immunomodulatory role of the pineal gland. Neuroendocrinol., Lett., 10:65-73, 1983.
108. Becker, J., Veit, G., Handgretinger, R., et al. Circadian variations in the immunomodulatory role of the pineal gland. Neuroendocrinol. Lett., 10:65-72, 1998.
109. Vermeulen, M., Palermo, M., and Giordano, M.: Neonatal pinealectomy impairs murine antibody-dependent cellular toxicity. J. Neuroimmunol., 43:97-101, 1993.
110. Del Gobbo, V., Libri, V., Villani, N., Callio, R., and Nistico, G.: Pinealectomy inhibits interleukin-2 production and natural killer activity in mice. Int. J. Immunopharmacol., 11:567-577, 1989.
111. Fraschini, F., Scaglione, F., Franco, P., Demartini, G., Lucini, V., and Stankov, B.: Melatonin and Immunity. Acta. Oncol., 5:775-776, 1990.
112. Maestroni, G. and Conti, A.: The pineal neurohormone melatonin stimulates activated CD4+, Thy-1+ cells to release opioid agonists with immunoenhancing and anti-stress properties. J. Neuroimmunol., 28:167-176, 1990.
113. Mocchegiani, E., Bulian, D., Santarelli, L., Tibaldi, A., Muzzioli M., Pierpaoli, W., and Fabris, N.J.: The immuno-reconstituting effect of melatonin or pineal grafting and its relation to zinc pool in aging mice, Neuroimmunol., 53:189-196, 1994.
114. Ben-Nathan D., Maestroni, G.M., and Conti, A.: Protective effect of melatonin in mice infected with encephalitis viruses. Arch. Virol., 140:223-230, 1995.
115. Pierpaoli, W. and Regelson, W.: Pineal control of aging: Effect of melatonin and pineal grafting on aging mice. Proc. Natl. Acad .Sci. USA, 91:787-791, 1994.
116. Provinciali, M., Stefano, G., Bulian, D., Tibaldi, A., and Fabris, N.: Effect of melatonin and pineal grafting on thymocyte apoptosis in aging mice, Mech. Ageing & Dev., 90:1-9, 1996.
117. Maestroni, G.J.: T-helper-2 lymphocytes as a peripheral target of melatonin. J. Pineal Res., 18:84-89, 1995.
118. Csaba, G., and Barath, P.: Morphological changes of thymus and the thyroid gland after postnatal extirpation of the pineal body. Endocrinol. Exp., 9:59-67, 1975.
119. Maestroni, G.J, Conti, A., and Pierpaoli, W.: Role of the pineal gland in immunity. III. Melatonin antagonizes the immunosuppressive effect of acute stress via an opiatergic mechanism, Immunology, 63:465-476, 1988.
120. Pioli, C., Caroleo, M.C., Nistico, G., and Doria, D.: Melatonin increases antigen presentation and amplifies specific and nonspecific signals for T cell proliferation. Int. J. Immunopharmacol., 15:463-469, 1993.
121. Sainz, R.M., Mayo, J.C., Urfa, H., Kotler, M., Antolin, A., Fodriguez, C., and Pelaex, A.: The pineal neurohormone melatonin prevents in vivo and in vitro apoptosis in thymocytes. J. Pineal Res., 19:178-188, 1995.
122. Pahlavani, M.A. and Harris, M.D.: In vitro effects of melatonin on mitogen-induced lymphocyte proliferation and cytokine expression in young and old rats, Immunopharmacol. & Immunotoxicol., 19:327-337, 1997.
123. Vaughan, M.K., Hubbard, G.B., Champeny, T.H., Little, J.C., and Reiter, R.J.: Splenic hypertrophy and extramedullary hematopoiesis induced in male Syrian hamsters by short photoperiod or melatonin injections reversed by melatonin pellets or pinealectomy. Am. J. Anat., 179:131-136, 1978.
124. Morrey, M.K. McLachlan, J.A., Serkin, D.C., and Bakouche, O.: Activation of human monocytes by the pineal neurohormone melatonin. J. Immunol., 153:2671-2680, 1994.
125. Lissoni, P., Pittalis, S., Brivio, F., Tisi, E., Rovelli, F., Ardizzovia A., Barni, S., Tanicini, G., Giudici, G., Biondi, A., Conti, A., and Maestroni, G.: In vitro modulatory effects of interleukin-3 on macrophage activation induced by interleukin-2. Cancer, 71:2976-2981, 1993.
126. Vijayalaxmia, R., Reiter, R. J., and Meltz, M.L.: Melatonin protects human blood lymphocytes from radiation-induced chromosome damage. Mutation Res., 346:23-31, 1995.
127. Karasek, M., Liberski, P., Radek, J., and Bartkowiak, J.: Influence of melatonin on the proliferation of hepatoma cells in the Syrian hamster: In vivo and in vitro study, Rovelli, F., Cattaneo, G., Archili, C., and Barni, S.: Serum interleukin-2 levels in relation to the neuroendocrine status in cancer patients. Br. J. Cancer, 62:838-839, 1990.
128. Das Gupta, T.K.: Influence of pineal gland on the growth and spread of melanoma in hamsters. Cancer Res., 19:83-84, 1968.
129. Stanberry, L.R., Das Gupta, T.K., and Beattle, C.W.: Photoperiodic control of melanoma growth in hamsters: Influence of pinealectomy and melatonin. Endocrinology, 113:469-475, 1983.
130. Tamarkin, L., Cohen, M., and Roselle, D.: Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenzanthracene induced mammary tumor in therats. Cancer Res 1981, 41:432-436, 1981.
131. Blask, D.E. and Hill, S. M.: Melatonin and Cancer: Basic and clinical aspects. In: Miles A., Philbrick, D.R., Thompson, C. (Eds.) Melatonin: Clinical Aspects. Oxford University, Oxford U.K, pp. 128-173, 1988.
132. Lissoni, P., Barni, S., Crispino, S., Tancini, G., and Fraschini, F.: Endocrine and immune effects of melatonin therapy in metastatic cancer patients. Eur. J. Cancer Clin. Oncol., 25:789-792, 1989.
133. Conti, A. and Maestroni, G.M.: The clinical neuroimmunotherapeutic role of melatonin in oncology. J. Pineal Res., 10:103-110, 1995.
134. Lissoni, P., Barni, S., Gazzaniga, M., Ardizzoia, A., Rovelli, F., Brivio, F., and Tancini, G.: Efficacy of the concomitant administration of the pineal hormone melatonin in cancer immunotherapy with low-dose IL-2 in patients with advanced solid tumors who had progressed on IL-2 alone. Oncology, 51:344-347, 1994.
135. Lissoni, P., Tisi, E., Barni, S.: Biological and clinical results of a neuroimmuno-therapy with IL-2 and the pineal hormone melatonin as a first line treatment in advanced non-small cell lung cancer. Br. J. Cancer, 66:155-158, 1992.
136. Neri, B., Fiorelli, C., Moroni, F.: Modulation of human lymphoblastoid interferon activity by melatonin in metastatic renal cell carcinoma. Cancer, 73:3015-5019, 1994.
137. Lissoni, P., Barni, S., Ardizzoia, A., Paolorossi, F., Crispino, S.: Randomized study with the pineal hormone melatonin versus supportive care alone in advanced nonsmall cell lung cancer resistant to first-line chemotherapy containing cisplatin. Oncology, 49: 336-339, 1992.
138. Lissoni, P., Barni, S., Rovelli, F., Brivio, F., Ardizzoia, A., Tancini, G., Conti, A, and Maestroni, G.J: Neuroimmunotherapy of advanced solid neoplasms with single evening subcutaneous injection of low-dose IL-2 and melatonin: Preliminary results. Eur. J. Cancer., 29A: 185-189, 1993.
139. Lissoni, P., Barni, S., Tancini, G.: Immunotherapy with subcutaneous low-dose IL-2 and the pineal indole melatonin as a new effective therapy in advanced cancers of the digestive tract. Br. J. Cancer, 67:1404-1407, 1993.
140. Lissoni, P., Brivio, F., Brivio, O., Fumagalli, L., Gramazio, F., Rossi, M., Emanuelli, G., Alden, G., and Lavorato. F.: Immune effects of preoperative immunotherapy with high-dose subcutaneous interleukin-2 versus neuroimmunotherapy with low-dose interleukin-2 plus the neurohormone melatonin in gastrointestinal tract tumor patients. J. Biol. Regul. Homeost. Agents, 9:31-33, 1995.
141. Lissoni, P., Barni, S., Ardizzoia, A., Tancini, G., Conti, A, and G.J. Maestroni, G.M.: A randomized study with the pineal hormone melatonin versus supportive care alone in patients with brain metastases due to solid neoplasms. Cancer, 73:699-701, 1994.
142. Lissoni, P., Barni, S., Tancini, G., Mainini, E., Piglia, F., and Maestroni, G.M.: Immunoendocrine therapy with low-dose subcutaneous interleukin-2 plus melatonin locally advanced or metastatic endocrine tumors. Oncology, 52:163-166, 1995.
143. Lissoni, P., Brivio, F., Ardizzoia, A., Tancini, G., and Barni, S.: Subcutaneous therapy with low-dose IL-2 plus neurohormone melatonin in metastatic gastric cancer patients with low performance status. Tumori, 79:410-404, 1993.
144. Lissoni, P., Barni, S., Rovelli, F.: Neuroendocrine effects of subcutaneous IL-2 injection in cancer patients. Tumori, 77:212-215, 1991.
145. Lissoni, P., Barni, S., Tancini, G.: A randomized study with subcutaneous low-dose IL-2 alone vs. IL-2 plus the pineal hormone melatonin in advanced solid neoplasm other than renal cancer and melanoma. Br. J .Cancer, 69:196-199, 1994.
146. Lissoni, P., Meregalli, S., Fossati, V.: A randomized study of immunotherapy with low-dose subcutaneous IL-2 plus melatonin vs. chemotherapy with cisplatin and etoposide as first-line therapy for advanced non-small lung cancer. Tumori, 80:464-467, 1994.
147. Barni, S., Lissoni, P., Cazzaniga, M.: Neuroimmunotherapy with subcutaneous low-dose IL-2 and the pineal hormone melatonin as a second-line treatment in metastatic colorectal carcinoma. Tumori, 78:383-387, 1992.
148. Turek, F.W.: Melatonin hype hard to swallow. Nature, 379:295-296, 1996.
149. Cunningham, D.A., and Hill, J.S.: Effects of training on cardiovascular response to exercise. J. Appl. Physiol., 39:891-895, 1975.
150. Mahan, M.P. and Young, R.M.: Immune parameters of untrained or exercise-trained rats after exhaustive exercise. J. Appl. Physiol.,66:282-287, 1989.
151. Shu, J., Stevenson, J.R., and Zhou, Z.: Modulation of cellular immune responses by cold water stress in the rat. Develop. Comp. Immunol., 17:357-371, 1993.
152. Ferry, A., Weill, B.L., and Rieu, A.M.: Immunomodulations induced in rats by exercise on a treadmill. J. Appl. Physiol., 69:1912-1915, 1990.
153. Fernandes, G, Rozek, M., and Troyer, D.: Reduction of blood pressure and restoration of T-cell immune function in spontaneously hypertensive rats by food restriction and/or by treadmill exercise. J. Hypertension, 4:5469-3474, 1986.
154. Tharp, G.D. and Preuss, T.L.: Mitogenic response of T lymphocytes to exercise training and stress. J. Appl. Physiol., 70:2535-25-38, 1991.
155. Simpson, J.R. and Hoffman-Goetz, L.: Exercise stress and murine natural killer cell function. Proc. Soc. Exp. Biol. Med., 195:129-135, 1990.
156. Ortega, E., Fomer, M.A., Barriga, C., and De La Fuente, M.: Effect of age and of swimming-induced stress on the phagocytic capacity of peritoneal macrophages from mice. Mech. Ageing Dev., 70:53-63, 1993.
157. Filteau, S.M., Menzies, R.A., Kaido, T.J., O'Grady, M.P., Gelderd, J.B., and Hall, N.R.: Effects of exercise on immune functions of undernourished mice. Life Sci., 51:565-574, 1992.
158. De La Fuente, M., Fernandez, M.D., Miguel, J., and Hernanz, A.: Changes with aging and physical activity in ascorbic acid content and proliferative response of murine lymphocytes. Mech. Ageing Dev., 65:177-186, 1992.
159. Hoffman-Goetz, L., Keir, R., Thorne, R., Houston, M.E., and Young, C.: Chronicexercise stress in mice depresses splenic T lymphocyte mitogenesis in vitro. Clin. Exp. Immunol., 66:551-557, 1986.
160. Conn, C.A., Rozak, W.E., Tooten, P.J., Gruys, E., Borer, K.T., and Kluger, M.J.: Effect of voluntary exercise and food restriction in response to lipopolysaccharide in hamsters. J. Appl. Physiol., 78:466-477, 1995.
161. Tomasi, T.B., Thudeau, F.B., Czerwinski, D., and Erredge, S.: Immune parameters in athletes before and after strenuous exercise. J. Clin. Immunol., 2:173-177, 1982.
162. Crist, D.M., Mackinnon, L.T., Thompson, R.F., Atterbon, H.A., and Egan, P.A.: Physical exercise increases natural cellular-mediated tumor cytotoxicity in elderly women. Gerontol., 35:66-71, 1989.
163. Papa, S., Vitale, M., Mazzotti, G., Neri, L., Monti, G., and Manzoli, F.: Impaired lymphocyte stimulation induced by long-term training. Immunol. Lett., 22:29-33, 1989.
164. MacNeil, B., Hoffman-Goetz, L., Kendall, A., Houston, M., and Arumagam, Y.: Lymphocyte proliferation responses after exercise in men: fitness, intensity, and duration. J. Appl. Physiol., 70:179-185, 1991.
165. Eskola, J., Ruuskanen, E., Soppi, E.: Effect of sport stress on lymphocyte transformation and antibody production. Clin. Exp. Immunol., 32:339-345, 1978.
166. Lewicki, R., Tchorzewski, H., Majewska, E., Nowak, Z., and Baj, Z.: Effect of maximal physical exercise on T lymphocyte subpopulations and on interleukin-1 (IL-1) and interleukin-2 (IL-2) production in vitro. Int. J. Sports Med., 9:114-117, 1988.
167. Fiatarone, M.A., Morley, J.E., Bloom, E.T., Benton, D., Solomon, G.F., and Makinodan, T.: The effect of exercise on natural killer cell activity in young and old subjects. J. Gerontol., 44:M37-45, 1989.
168. Ferry, A., Picard, F., Duvallet, A., Weill, B., and Rieu, M.: Changes in blood leukocyte populations induced by acute maximal and chronic submaximal exercise. Eur. J. Appl. Physiol., 59:435-442, 1990.
169. Hanson, P.G., and Flaherty, D.K.: Immunological responses to training in conditioned runners. Clin. Sci., 60:225-228, 1981.
170. Liu, Y.G., and Wang, S.Y.: The enhancing effect of exercise on production of antibody to Salmonella typhi in mice. Immunol. Lett., 14:117-120, 1987.
171. Peters, B.A., Sothmann, M., and Wehrenberg, W.B.: Blood leukocyte and spleen lymphocyte immune responses in chronically physically active and sedentary hamsters. Life Sci., 45:2238-2245, 1989.
172. Hedfors, E., Holm, G., and Ohnel, B.: Variations of blood lymphocytes during work studied by cell surface markers, DNA synthesis, and cytotoxicity. Clin. Exp. Immunol., 24:328-335, 1976.
173. Hoffman-Goetz, L., Keir, R., Thorne, R., Houston, M.E., and Young, C.: Chronicexercise stress in mice depresses splenic T lymphocyte mitogenesis in vitro. Clin. Exp. Immunol., 66:551-557, 1986.
174. Oshida, Y., Yamanouchi, K., Hayamizu, U., and Sato, Y.: Effect of acute
175. Fitzgerald, L.: Exercise and immune system. Immunol. Today, 11:337-339, 1988.
176. Khansari, D.N., Murgo, A.J., and Faith, R.E.: Effects of stress on immune system. Immunol. Today, 11:170-175, 1990.
177. Hoffman-Goetz, L., Thorne, R.J., and Houston, M.E.: Splenic immune responses following treadmill exercise in mice. Can. J. Physiol. Pharmacol., 66:1405-1419, 1988.
178. Rall, L.C., Roubenoff, R., Cannon, J.G., Abad, L.W., Dinarello, C.A., and Meydani, S.N.: Effects of progressive resistance training on immune response in aging and chronic inflamation. Med. Sci. Sports Exerc. 28:1356-1365, 1996.
179. Nieman, D.C., Henson, D.A., and Gusewitch, G.: Physical activity and immune function in eldely women. Med. Sci. Sports Exer., 25:823-831, 1993.